MedPath
TGA Approval

RIVASTIGMINE-DRLA rivastigmine (as hydrogen tartrate) 6 mg capsule blister pack (177408)

177408

RIVASTIGMINE-DRLA rivastigmine (as hydrogen tartrate) 6 mg capsule blister pack

Dr Reddys Laboratories Australia Pty Ltd

September 25, 2012

Medicine

Medicine

Active

Registered

Active Ingredients

rivastigmine hydrogen tartrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RIVASTIGMINE-DRLA rivastigmine (as hydrogen tartrate) 6 mg capsule blister pack (177408) - TGA 批准文号 | MedPath